HRP920191B1 - New glycopeptides, process for the preparation and application thereof - Google Patents

New glycopeptides, process for the preparation and application thereof

Info

Publication number
HRP920191B1
HRP920191B1 HRP4134611.4A HRP920191A HRP920191B1 HR P920191 B1 HRP920191 B1 HR P920191B1 HR P920191 A HRP920191 A HR P920191A HR P920191 B1 HRP920191 B1 HR P920191B1
Authority
HR
Croatia
Prior art keywords
compound
formula
preparation
application
glycopeptides
Prior art date
Application number
HRP4134611.4A
Other languages
English (en)
Inventor
Michael Limbert
Original Assignee
Michael Limbert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4121662A external-priority patent/DE4121662A1/de
Application filed by Michael Limbert filed Critical Michael Limbert
Publication of HRP920191A2 publication Critical patent/HRP920191A2/hr
Publication of HRP920191B1 publication Critical patent/HRP920191B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HRP4134611.4A 1991-06-29 1992-06-26 New glycopeptides, process for the preparation and application thereof HRP920191B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4121662A DE4121662A1 (de) 1991-06-29 1991-06-29 Neue glycopeptide, verfahren zu ihrer herstellung und ihre verwendung
DE4134611 1991-10-19

Publications (2)

Publication Number Publication Date
HRP920191A2 HRP920191A2 (hr) 1994-04-30
HRP920191B1 true HRP920191B1 (en) 1997-12-31

Family

ID=25905082

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP4134611.4A HRP920191B1 (en) 1991-06-29 1992-06-26 New glycopeptides, process for the preparation and application thereof

Country Status (23)

Country Link
US (1) US5763397A (xx)
EP (1) EP0521408B1 (xx)
JP (1) JP2959911B2 (xx)
KR (1) KR100243962B1 (xx)
AT (1) ATE142226T1 (xx)
AU (2) AU660682B2 (xx)
CA (1) CA2072725A1 (xx)
CZ (1) CZ284310B6 (xx)
DE (1) DE59207033D1 (xx)
DK (1) DK0521408T3 (xx)
ES (1) ES2091369T3 (xx)
FI (1) FI106032B (xx)
GR (1) GR3021042T3 (xx)
HR (1) HRP920191B1 (xx)
HU (1) HU214057B (xx)
IE (1) IE74901B1 (xx)
IL (1) IL102326A (xx)
NO (1) NO306950B1 (xx)
NZ (1) NZ243345A (xx)
RU (1) RU2099349C1 (xx)
SI (1) SI9200126A (xx)
TW (1) TW213468B (xx)
YU (1) YU48512B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19523394A1 (de) * 1995-06-28 1997-01-09 Hoechst Ag Verwendung von Balhimycin zur Leistungssteigerung bei Tieren sowie leistungssteigernde Mittel
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US5977063A (en) * 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5919771A (en) * 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
DE19926770A1 (de) 1999-06-11 2000-12-14 Basf Ag Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
KR20110127732A (ko) * 2000-12-18 2011-11-25 큐비스트 파마슈티컬즈 인코포레이티드 정제된 리포펩티드의 제조 방법
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
RU2607526C2 (ru) 2009-11-23 2017-01-10 Кьюбист Фармасьютикалз ЭлЭлСи Липопептидные композиции и родственные способы

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
DE3420596C2 (de) * 1984-06-01 1986-10-02 Dr.-Ing. Ludwig Pietzsch Gmbh & Co, 7505 Ettlingen Überwachungs- und Steuersystem für Auslegerkrane
JPH0662674B2 (ja) * 1985-01-11 1994-08-17 三共株式会社 抗生物質クロロポリスポリンｂまたはｃ
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
DE3713757A1 (de) * 1987-04-24 1988-11-10 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
NZ236393A (en) * 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
IN171883B (xx) * 1990-07-27 1993-01-30 Hoechst India

Also Published As

Publication number Publication date
HU214057B (en) 1997-12-29
FI922954A (fi) 1992-12-30
AU1857592A (en) 1993-01-07
EP0521408B1 (de) 1996-09-04
IL102326A0 (en) 1993-01-14
DK0521408T3 (xx) 1997-01-20
NZ243345A (en) 1994-09-27
HRP920191A2 (hr) 1994-04-30
HUT63462A (en) 1993-08-30
NO306950B1 (no) 2000-01-17
ATE142226T1 (de) 1996-09-15
SI9200126A (en) 1992-12-31
YU48512B (sh) 1998-09-18
EP0521408A1 (de) 1993-01-07
ES2091369T3 (es) 1996-11-01
DE59207033D1 (de) 1996-10-10
JPH05271284A (ja) 1993-10-19
KR100243962B1 (ko) 2000-02-01
RU2099349C1 (ru) 1997-12-20
GR3021042T3 (en) 1996-12-31
FI922954A0 (fi) 1992-06-25
YU60392A (sh) 1994-09-09
NO922520L (no) 1992-12-30
CZ284310B6 (cs) 1998-10-14
US5763397A (en) 1998-06-09
AU3308995A (en) 1996-01-25
JP2959911B2 (ja) 1999-10-06
HU9202163D0 (en) 1992-10-28
CA2072725A1 (en) 1992-12-30
FI106032B (fi) 2000-11-15
NO922520D0 (no) 1992-06-26
AU687612B2 (en) 1998-02-26
KR930000537A (ko) 1993-01-15
IE922115A1 (en) 1992-12-30
TW213468B (xx) 1993-09-21
AU660682B2 (en) 1995-07-06
IE74901B1 (en) 1997-08-13
IL102326A (en) 1996-07-23
CZ199192A3 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
HUT56333A (en) Halogenated hydrocarbon solvent preparations and process for their applications
AU2205592A (en) 1,2-dihydro-2-oxopyridine
AU7607991A (en) Method of inhibiting gastric acid secretion
AU1966392A (en) 8-vinyl- and 8-ethinyl-quinolone-carboxylic acids
HRP920191B1 (en) New glycopeptides, process for the preparation and application thereof
GR3024859T3 (en) 4,13-dioxabicyclo[8.2.1]tridecenon-derivatives, method and intermediates for their preparation, and medicaments containing the same
AU1629792A (en) Gallium compounds
AU3689193A (en) Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
AU1925392A (en) A process for the preparation of n-(2,6-dichlorophenyl)-n-phenyl-n-(chloroacetyl)-amine
CA2034979A1 (en) Antibiotic, deoxymulundocandin, a process for its production and its useas medicament
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
AU1662092A (en) Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
EP0534449A3 (en) Process for the preparation of 3-aminomethyl-3,5,5-trialkylcyclohexylamine
IN171883B (xx)
AU7812791A (en) Dichloroaniline compound
IE881937L (en) Preparation of antibiotic furmifungin
AU8072391A (en) Oxalate degrading bacterium
AU7653491A (en) Glycopeptides antibiotics
AU8766591A (en) Assay for cyclic 1,2-dithiol-3-ones
GB9126756D0 (en) 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20000622

Year of fee payment: 9

PBON Lapse due to non-payment of renewal fee

Effective date: 20010623